Senior Director, Vaccines

Overview

The Clinton Health Access Initiative, Inc. (CHAI) is a global health organization committed to our mission of saving lives and reducing the burden of disease in low-and middle-income countries. We work at the invitation of governments to support them and the private sector to create and sustain high-quality health systems.

 

CHAI was founded in 2002 in response to the HIV/AIDS epidemic with the goal of dramatically reducing the price of life-saving drugs and increasing access to these medicines in the countries with the highest burden of the disease. Over the following two decades, CHAI has expanded its focus. Today, along with HIV, we work in conjunction with our partners to prevent and treat infectious diseases such as COVID-19, malaria, tuberculosis, and hepatitis. Our work has also expanded into cancer, diabetes, hypertension, and other non-communicable diseases, and we work to accelerate the rollout of lifesaving vaccines, reduce maternal and child mortality, combat chronic malnutrition, and increase access to assistive technology. We are investing in horizontal approaches to strengthen health systems through programs in human resources for health, digital health, and health financing. With each new and innovative program, our strategy is grounded in maximizing sustainable impact at scale, ensuring that governments lead the solutions, that programs are designed to scale nationally, and learnings are shared globally.

 

At CHAI, our people are our greatest asset, and none of this work would be possible without their talent, time, dedication and passion for our mission and values. We are a highly diverse team of enthusiastic individuals across 40 countries with a broad range of skillsets and life experiences. CHAI is deeply grounded in the countries we work in, with majority of our staff based in program countries. Learn more about our exciting work: http://www.clintonhealthaccess.org

 

CHAI is an Equal Opportunity Employer, and is committed to providing an environment of fairness, and mutual respect where all applicants have access to equal employment opportunities. CHAI values diversity and inclusion and recognizes that our mission is best advanced by the leadership and contributions of people with diverse experience, backgrounds, and culture.

 

Overview of CHAI’s Global Vaccines Program

 

Immunization is a powerful tool for saving lives and improving health outcomes globally. Since the Expanded Program on Immunization (EPI) was launched in 1974, two to three million deaths have been averted each year, globally. For every dollar invested in immunization, there is a US$16 return, making it one of the most cost effective public health interventions available.  

 

However, despite these tremendous successes, significant gaps still remain, with 2 million children (primarily in lower-income and lower-middle income countries) dying each year from vaccine- preventable diseases, and an estimated 20 million children still under-immunized.

 

Improvements in coverage and equity have been slow, and more innovative approaches (products, practices, systems, and policies) need to be developed, scaled up and implemented globally. Moreover, national immunization programs face unprecedented challenges due to the introduction of costly, and more complex vaccines, and, for some countries, the impending transition from Gavi support. These challenges pose a significant threat to the sustainability of the gains in coverage and equity that have been made by national immunization programs and partners over the past four decades.

 

Since 2010, CHAI has worked to save lives and reduce the burden from vaccine preventable diseases by supporting access to immunization services in resource-limited settings by strengthening national immunization programs and improving availability, affordability, and diversity of supply for existing and future Gavi vaccines and cold-chain equipment. Specifically, this work includes:

 

·       Improving affordability and supply security of immunization products

·       Accelerating the uptake of new or under-utilized vaccines

·       Enhancing the performance of vaccine cold chain and logistics systems to increase effective immunization coverage

·       Improving the design and implementation of service delivery to reach the unreached

·       Supporting successful transition from Gavi support

·       Strengthening the management systems and capacity of immunization programs

 

CHAI’s two teams working on vaccines, the Global Vaccines Delivery (GVD) team and the Vaccines Market Team (VMT) have distinct but inherently interlinked roles in achieving this work. GVD works closely with CHAI’s country teams to support national immunization programs achieve scalable and sustainable impact. VMT